Today's Insider Trading Highlights — June 05, 2026
📅 Published: June 05, 2026 at 12:29 PM UTC
4 Cluster Buys5 Insider Purchases
On June 05, 2026, we detected 4 new cluster buys including a $2.2M purchase in $SMMT by 2 insiders, and 5 notable insider purchases. SARVADI PAUL J (Director) bought $7.9M of $NSP. Data sourced from SEC Form 4 filings analyzed by Average Insider.
⚠️ For information purposes only. This information is provided for informational purposes only and does not constitute investment advice, financial advice, trading advice, or any other type of advice. All investments carry risk, including the potential loss of principal. Past performance is not indicative of future results. You should consult with a qualified financial advisor, accountant, or other professional before making any investment decisions. The information contained in this newsletter is not intended to be a substitute for professional financial advice.
📊 Insider Trading Insights — June 05, 2026
Tracking insider purchases and cluster buys over the past 7 days. Insider buying can indicate confidence in a company's future, while cluster buys (multiple insiders buying around the same time) are particularly noteworthy signals.
🔥 Cluster Buys
$14.84
Current Price
52W: $13.83 – $30.98
$0.25
Fair Value
Participants 2 insiders | Total Shares 150,000 | Total Value $2,182,250 |
Timeframe 0 days | Date Range Jun 04, 2026 – Jun 04, 2026 |
👥 Participant Details
P&L: +2.6% (+$9,500) |
P&L: +2.8% (+$10,250) | ||||
P&L: +1.6% (+$24,000) |
📊 Valuation & Analyst Info
Fair Value: $0.25 (-98.3% overvalued vs current price)
P/E Ratio: -12.1
Analyst Consensus: Buy
Price Target: $19.00 (Low: $16.00 | High: $23.00 | Median: $18.00)
📰 Recent News (Last 7 Days)
$19.70
Current Price
52W: $7.70 – $21.42
Participants 2 insiders | Total Shares 65,519 | Total Value $1,254,414 |
Timeframe 0 days | Date Range Jun 03, 2026 – Jun 03, 2026 |
👥 Participant Details
P&L: +1.4% (+$13,910) |
P&L: +8.8% (+$22,400) |
📊 Valuation & Analyst Info
P/E Ratio: 0.0 (1.0x below Waste Management avg (463.1)) (1.0x below Industrials avg (43.8))
Applied Aerospace & Defense, Inc.
Ticker: AADX
$18.60
Current Price
52W: $18.39 – $20.95
Participants 4 insiders | Total Shares 58,500 | Total Value $1,170,000 |
Timeframe 0 days | Date Range Jun 04, 2026 – Jun 04, 2026 |
👥 Participant Details
P&L: -7.0% ($35,000) |
P&L: -7.0% ($35,000) | ||||
P&L: -7.0% ($700) |
P&L: -7.0% ($11,200) |
$146.41
Current Price
52W: $140.63 – $354.88
$-32.21
Fair Value
Participants 2 insiders | Total Shares 6,240 | Total Value $897,883 |
Timeframe 0 days | Date Range Jun 03, 2026 – Jun 03, 2026 |
👥 Participant Details
P&L: +1.5% (+$7,625) |
P&L: +2.0% (+$8,091) |
📊 Valuation & Analyst Info
Fair Value: $-32.21 (-122.0% overvalued vs current price)
P/E Ratio: 80.9 (1.1x above Medical - Devices avg (39.2)) (2.1x above Healthcare avg (26.1))
Analyst Consensus: Buy
Price Target: $227.00 (Low: $198.00 | High: $280.00 | Median: $220.00)
📰 Recent News (Last 7 Days)
💰 Individual Insider Buys
$33.47
Current Price
52W: $18.57 – $64.22
$89.45
Fair Value
Transaction Date Jun 03, 2026 | Shares 233,000 | Purchase Price $34.05 |
Purchase Value $7,933,650 |
P&L: -1.7% ($135,140)
📊 Valuation & Analyst Info
Fair Value: $89.45 (+167.2% undervalued vs current price)
P/E Ratio: -210.2
Analyst Consensus: Hold
Price Target: $52.00 (Low: $36.00 | High: $62.00 | Median: $55.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-08-03
$82.70
Current Price
52W: $29.60 – $99.86
$-150.31
Fair Value
Transaction Date Jun 03, 2026 | Shares 47,058 | Purchase Price $85.00 |
Purchase Value $3,999,930 |
P&L: -2.7% ($108,233)
📊 Valuation & Analyst Info
Fair Value: $-150.31 (-281.8% overvalued vs current price)
P/E Ratio: -48.9
Analyst Consensus: Buy
Price Target: $75.00 (Low: $62.00 | High: $85.00 | Median: $78.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-08-04
Transaction Date Jun 01, 2026 | Shares 330,000 | Purchase Price $10.00 |
Purchase Value $3,300,000 |
📊 Valuation & Analyst Info
P/E Ratio: 18.8
Analyst Consensus: Buy
$16.37
Current Price
52W: $7.29 – $16.88
$-49.04
Fair Value
Transaction Date Jun 02, 2026 | Shares 206,005 | Purchase Price $15.28 |
Purchase Value $3,147,756 |
P&L: +7.1% (+$224,545)
📊 Valuation & Analyst Info
Fair Value: $-49.04 (-399.6% overvalued vs current price)
P/E Ratio: 7.5 (0.7x below Biotechnology avg (24.2)) (0.7x below Healthcare avg (26.1))
Analyst Consensus: Buy
Price Target: $12.60 (Low: $6.00 | High: $16.00 | Median: $13.00)
$13.78
Current Price
52W: $10.12 – $16.26
$-214.95
Fair Value
Transaction Date Jun 02, 2026 | Shares 230,847 | Purchase Price $13.41 |
Purchase Value $3,096,374 |
P&L: +2.7% (+$84,698)
📊 Valuation & Analyst Info
Fair Value: $-214.95 (-1659.9% overvalued vs current price)
P/E Ratio: -24.6
Analyst Consensus: Strong Buy
Price Target: $18.00 (Low: $18.00 | High: $18.00 | Median: $18.00)
📰 Recent News (Last 7 Days)
📈 Recent Earnings: 2026-08-04
⚠️ Important Disclaimers
Investment Disclaimer: This content is for informational purposes only and should not be considered investment advice.
Data Accuracy: All information is sourced from SEC filings and third-party data providers. Errors or omissions may occur.
Market Risks: Past insider buying activity does not guarantee future performance.
Professional Advice: Consult with qualified financial professionals before making any investment decisions.
📚 Deep Dive Resources
Data sourced from SEC filings. This is for informational purposes only.
Want to receive these newsletters in your inbox? Sign up here